Functional impairment of the arterial wall in primary Sjögren's syndrome: Combined action of immunologic and inflammatory factors

Arthritis Care and Research

Volumn 62, Issue 5, 2010, Pages 712-718

  Gerli, Roberto ^a   Vaudo, Gaetano ^a   Bocci, Elena Bartoloni ^a   Schillaci, Giuseppe ^a   Alunno, Alessia ^a   Luccioli, Filippo ^a   Hijazi, Raed ^a   Mannarino, Elmo ^a   Shoenfeld, Yehuda ^b  

^a UNIVERSITY OF PERUGIA   (Italy)

^b SHEBA MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; CYCLOOXYGENASE 2 INHIBITOR; INTERCELLULAR ADHESION MOLECULE 1; LA ANTIBODY; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE; RHEUMATOID FACTOR; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTERY BLOOD FLOW; ARTERY DISEASE; ARTERY ENDOTHELIUM; ARTICLE; ATHEROSCLEROSIS; CHRONIC DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; HUMAN; JOINT; LEUKOCYTE COUNT; LEUKOPENIA; PAROTID GLAND DISEASE; SJOEGREN SYNDROME; VASCULAR SMOOTH MUSCLE; VASODILATATION;

ADULT; ATHEROSCLEROSIS; BRACHIAL ARTERY; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MATCHED-PAIR ANALYSIS; MIDDLE AGED; REFERENCE VALUES; SJOGREN'S SYNDROME; STATISTICS, NONPARAMETRIC; TYROSINE; VASCULAR CELL ADHESION MOLECULE-1; VASODILATION;

EID: 77951726460     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/acr.20117     Document Type: Article

References (46)

1. Shoenfeld Y, Gerli R, Doria A, Matsuura E, Cerinic MM, Ronda N, et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 2005;112:3337-3347 (Pubitemid 43739380)
2. Salmon JE, Roman MJ. Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Am J Med 2008;121:S3-8.
3. Nurmohamed MT. Cardiovascular risk in rheumatoid arthritis. Autoimmun Rev 2009;8:663-667
4. Gerli R, Goodson NJ. Cardiovascular involvement in rheumatoid arthritis. Lupus 2005;14:679-682
5. Kaplan MJ. Premature vascular damage in systemic lupus erythematosus [review]. Autoimmunity 2009;47:580-586
6. Frostegard J. Systemic lupus erythematosus and cardiovascular disease. Lupus 2008;17:364-367 (Pubitemid 351798708)
7. Colombo BM, Cacciapaglia F, Puntoni M, Murdaca G, Rossi E, Rodriguez G, et al. Traditional risk factors and non traditional risk factors in accelerated atherosclerosis in systemic lupus erythematosus: role of endothelial growth factor (VEGATS Study). Autoimmun Rev 2009;8:309-315
8. Jonsson R, Bolstad AI, Brokstad KA, Brun J. Sjögren's syndrome: a plethora of clinical and immunological phenotypes with a complex genetic background. Ann N Y Acad Sci 2007;1108:433-447 (Pubitemid 47528757)
9. Delaleu N, Jonsson MV, Appel S, Jonsson R. New concepts in the pathogenesis of Sjögren's syndrome. Rheum Dis Clin North Am 2008;34:833-845
10. Theander E, Manthorpe R, Jacobsson LT. Mortality and causes of death in primary Sjögren's syndrome: a prospective cohort study. Arthritis Rheum 2004;50:1262-1269 (Pubitemid 38480838)
11. Voulgarelis M, Tzioufas AG, Moutsopoulos HM. Mortality in Sjögren's syndrome. Clin Exp Rheumatol 2008;26:S66-71.
12. Vaudo G, Bocci EB, Shoenfeld Y, Schillaci G, Wu R, Del Papa N, et al. Precocious intima-media thickening in patients with primary Sjögren's syndrome. Arthritis Rheum 2005;52:3890-3897 (Pubitemid 41798228)
13. Griffiths HR. Is the generation of neo-antigenic determinants by free radicals central to the development of autoimmune rheumatoid disease? Autoimmun Rev 2008;7:544-549
14. Forstermann U. Oxidative stress in vascular disease: causes, defense mechanisms and potential therapies. Nat Clin Pract Cardiovasc Med 2008;5:338-349 (Pubitemid 351761708)
15. Munzel T, Sinning C, Post F, Warnholtz A, Schulz E. Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction. Ann Med 2008;40:180-196 (Pubitemid 351482543)
16. Videm V, Albrigtsen M. Soluble ICAM-1 and VCAM-1 as markers of endothelial activation. Scand J Immunol 2008;67:523-531
17. Adams MR, Robinson J, McCredie R, Seale JP, Sorensen KE, Deanfield JE, et al. Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis. J Am Coll Cardiol 1998;32:123-127 (Pubitemid 28351052)
18. Raitakari OT, Seale JP, Celermajer DS. Impaired vascular responses to nitroglycerin in subjects with coronary atherosclerosis. Am J Cardiol 2001;87:217-219
19. Corretti M, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. J Am Coll Cardiol 2002;39:257-265
20. Hu R, Siu CW, Lau EO, Wang WQ, Lau CP, Tse HF. Impaired nitrate-mediated dilatation could reflect nitrate tolerance in patients with coronary artery disease. Int J Cardiol 2007;120:351-356 (Pubitemid 47069561)
21. Peluffo G, Radi R. Biochemistry of protein tyrosine nitration in cardiovascular pathology. Cardiovasc Res 2007;75:291-302. (Pubitemid 46961930)
22. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al, for the European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-558
23. Marchesi S, Lupattelli G, Schillaci G, Pirro M, Siepi D, Roscini AR, et al. Impaired flow-mediated vasoactivity during post-prandial phase in young healthy men. Atherosclerosis 2000;153:397-402. (Pubitemid 32120339)
24. Vaudo G, Marchesi S, Gerli R, Allegrucci R, Giordano A, Siepi D, et al. Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity. Ann Rheum Dis 2004;63:31-35 (Pubitemid 38064600)
25. Gerli R, Schillaci G, Giordano A, Bocci EB, Bistoni O, Vaudo G, et al. CD4+CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patients. Circulation 2004;109:2744-2748 (Pubitemid 38737922)
26. Kiss E, Soltesz P, Der H, Kocsis Z, Tarr T, Bhattoa H, et al. Reduced flow-mediated vasodilation as a marker for cardiovascular complications in lupus patients. J Autoimmun 2006;27:211-217 (Pubitemid 46206103)
27. Gerli R, Bocci EB, Vaudo G, Marchesi S, Vitali C, Shoenfeld Y. Traditional cardiovascular risk factors in primary Sjögren's syndrome: role of dyslipidaemia [letter]. Rheumatology (Oxford) 2006;45:1580-1581 (Pubitemid 44817075)
28. Yetik-Anacak G, Catravas JD. Nitric oxide and the endothelium: history and impact on cardiovascular disease. Vasc Pharmacol 2006;45:268-276 (Pubitemid 44765289)
29. Ghiadoni L, Mosca M, Tani C, Virdis A, Taddei S, Bombardieri S. Clinical and methodological aspects of endothelial function in patients with systemic autoimmune diseases. Clin Exp Rheumatol 2008;26:680-687
30. Doran AC, Meller N, McNamara CA. Role of smooth muscle cells in the initiation and early progression of atherosclerosis. Arterioscler Thromb Vasc Biol 2008;28:812-819 (Pubitemid 351544093)
31. Gerli R, Muscat C, Giansanti M, Danieli MG, Sciuto M, Gabrielli A, et al. Quantitative assessment of salivary gland inflammatory infiltration in primary Sjögren's syndrome: its relationship to different demographic, clinical and serological features of the disorder. Br J Rheumatol 1997;36:969-975 (Pubitemid 27450071)
32. Vestweber D. Adhesion and signaling molecules controlling the transmigration of leukocytes through endothelium. Immunol Rev 2007;218:178-196 (Pubitemid 47052303)
33. Turkcapar N, Sak SD, Saatci M, Duman M, Olmez U. Vasculitis and expression of vascular cell adhesion molecule-1, intercellular adhesion molecule-1, and E-selectin in salivary glands of patients with Sjögren's syndrome. J Rheumatol 2005;32:1063-1070 (Pubitemid 40828080)
34. Couffinhal T, Duplaa C, Moreau C, Lamaziere JM, Bonnet J. Regulation of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 in human vascular smooth muscle cells. Circ Res 1994;74:225-234 (Pubitemid 24029154)
35. Lee HM, Kim HJ, Won KJ, Choi WS, Park SH, Song H, et al. Soluble form of vascular cell adhesion molecule-1 induces migration and proliferation of vascular smooth muscle cells. J Vasc Res 2008;45:259-268 (Pubitemid 351543150)
36. Konttinen YT, Platts LA, Tuominen S, Eklund KK, Santavirta N, Tornwall J, et al. Role of nitric oxide in Sjögren's syndrome. Arthritis Rheum 1997;40:875-883 (Pubitemid 27200004)
37. Wanchu A, Khullar M, Sud A, Bambery P. Elevated nitric oxide production in patients with primary Sjögren's syndrome. Clin Rheumatol 2000;19:360-364 (Pubitemid 32053273)
38. Dawson L, Tobin A, Smith P, Gordon T. Antimuscarinic antibodies in Sjögren's syndrome: where are we, and where are we going? [review]. Arthritis Rheum 2005;52:2984-2995
39. Kovacs L, Feher E, Bodnar I, Marczinovits I, Nagy GM, Somos J, et al. Demonstration of autoantibody binding to muscarinic acetylcholine receptors in the salivary gland in primary Sjögren's syndrome. Clin Immunol 2008;128:269-276
40. Moutsopoulos HM, Elkon K, Mavridis AK, Acritidis NC, Hughes GR, Pepys MB. Serum C-reactive protein in primary Sjögren's syndrome. Clin Exp Rheumatol 1983;1:57-58 (Pubitemid 13049699)
41. Pirildar T, Tikiz C, Ozkaya S, Tarhan S, Utuk O, Tikiz H, et al. Endothelial dysfunction in patients with primary Sjögren's syndrome. Rheumatol Int 2005;25:536-539 (Pubitemid 41355571)
42. Vitali C, Bombardieri S, Moutsopoulos HS, Balestrieri C, Bencivelli W, Bernstein RM, et al. Preliminary criteria for the classification of Sjögren's syndrome: results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993;36:340-347 (Pubitemid 23090601)
43. Ramos-Casals M, Brito-Zeron P, Perez-De-Lis M, Jimenez I, Blanco MJ, Bove A, et al. Sjögren syndrome or Sjögren disease? The histological and immunological bias caused by the 2002 criteria. Clin Rev Allergy Immunol 2009. E-pub ahead of print.
44. Sacks D, Bakal CW, Beatty PT, Becker GJ, Cardella JF, Raabe RD, et al. Position statement on the use of the ankle-brachial index in the evaluation of patients with peripheral vascular disease: a consensus statement developed by the standards division of the Society Of Cardiovascular & Interventional Radiology [review]. J Vasc Interv Radiol 2002;13:353. (Pubitemid 34298812)
45. Rachapalli SM, Kiely PD, Bourke BE. Prevalence of abnormal ankle brachial index in patients with primary Sjögren's syndrome. Clin Rheumatol 2009;28:587-590
46. Avalos I, Rho YH, Chung CP, Stein CM. Atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Rheumatol 2008;26:S5-13.